Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Bicalutamide

Review the clinical trials studying bicalutamide on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-6 of 6

Two Studies for Patients with Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients with a Low Gene Risk Score and Testing a More Intense Treatment for Patients with a Higher Gene Risk Score, The Guidance Trial
Status: Active
Location: 553 locations
Comparing the Outcome of Standard Systemic Therapy Only versus Standard Systemic Therapy with Either Surgery or Radiation Therapy, for Patients with Advanced Prostate Cancer
Status: Active
Location: 325 locations
Talazoparib with Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer, TRIPLE-PRO Trial
Status: Active
Location: 5 locations
Abemaciclib and Bicalutamide for the Treatment of Locally Advanced, Unresectable, or Metastatic Androgen Receptor-Positive, HER2-Negative Breast Cancer
Status: Active
Location: 4 locations
Leuprolide and Abiraterone Acetate (AA) versus Relugolix and AA for the Treatment of Non-Metastatic Recurrent Prostate Cancer, the REVELUTION-2 Trial
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Radiation Therapy Using MRI-Guided Dosing for Prostate Cancer to Preserve Quality of Life
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois